Dr. Daniel J. Boffa is a professor of thoracic surgery at Yale School of Medicine.

Dr. Daniel J. Boffa

Dr. Daniel J. Boffa shared how cancer care teams support patients in quitting smoking and how new data may guide improvements in high-smoking U.S. regions.

How Cancer Care Teams Can Help With the Cessation of Smoking

Yale Cancer Center-led research published in 

 found that 47% of patients diagnosed with cancer in were former or current smokers, compared with 12% of the general U.S. population.

Because of the difference between smokers and never-smokers being diagnosed with cancer, there are initiatives aimed at these individuals aiming to drive the cessation of smoking after a cancer diagnosis. For example, there are different types of therapy, medications and support groups for those trying to quit the habit, Dr. Daniel J. Boffa explained in an interview with CURE.

 patients can expect from their cancer care team when trying to quit smoking. He also goes on to share how this new smoking data may guide future improvements in cancer care, specifically in regions of the United States with high rates of active smoking.

Boffa currently serves as a professor of Surgery (Thoracic); division chief of Thoracic Surgery; and clinical director at the Center for Thoracic Cancers, at Yale School of Medicine, Yale Cancer Center, located in New Haven, Connecticut.

The good news is that there is a lot of help available. There are quit lines, and most hospitals have teams prepared to help people quit — their smoking cessation teams. The first step is to have that conversation and then to realize that there are tremendous benefits, even after a cancer diagnosis.

There are different types of therapy, different types of medication, and different levels of support groups that can help people make this change, which, while difficult, offers returns that are as significant and beneficial as some of our most innovative cancer treatments.

I think this illustrates that the cancer landscape in the United States is not uniform, and there are differences in behaviors of people in different parts of the country, as well as differences in cancer prevalence across the country. Active smoking is more common in several regions, such as the South. Resources can be directed to hospitals in these areas to help strengthen their smoking cessation efforts.

Additionally, there are higher rates of active smoking across different cancer types. For instance, lung cancer has one of the higher rates, whereas thyroid cancer would have a significantly lower rate. Therefore, I think that hospitals treating a greater proportion of lung cancer patients would benefit from additional support efforts, while hospitals in different parts of the country, like the South, where active smoking rates are higher, could benefit from additional resources.

Transcript has been edited for clarity and conciseness.

For more news on cancer updates, research and education, don’t forget to 

Videos

Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.

Smoking Data May Guide Improved Lung Cancer Care and Patient Support

A new study investigated how often smoking discussions are documented at cancer–accredited hospitals, where 70% of patients with new cancer diagnoses receive care, according to Dr. Daniel J. Boffa, a professor of thoracic surgery at Yale School of Medicine. The team found that smoking status was recorded in 97% of cases, an encouraging sign of quality communication between patients and providers.

The study also examined new variables of current, former or never smoking status using the National Cancer Database, which revealed that nearly half of patients had a history of tobacco use. In addition, 15% of patients were still smoking at diagnosis, which gives them the opportunity to quit even after diagnosis.

Smoking can affect how cancer behaves and responds to treatment, with smoking-related cancers often showing different genetic patterns than those found in non-smokers, according to Boffa. He also emphasized that patients can expect robust cessation support, including hospital teams, medications and quit lines.

Well, I think the most actionable finding was that about 15% of people were actively smoking at the time of their diagnosis, and that's a real opportunity to make a difference, because quitting at the time of a cancer diagnosis can really help improve outcomes.

There truly is no point in time when quitting smoking is not a benefit to patients. It's hard when you're diagnosed with cancer—it's a very stressful time, and that's when it's even more difficult to quit a behavior you've been doing for a while.

But the payoff is real. Treatments are associated with fewer complications when you quit smoking, and the treatments can work more effectively. The behavior of the cancer itself can actually improve, and there's a lower chance that the cancer will come back. So, there are tremendous benefits to quitting, even if you've already been diagnosed with cancer.

Dr. Daniel J. Boffa

How Cancer Care Teams Can Help With the Cessation of Smoking

Smoking Data May Guide Improved Lung Cancer Care and Patient Support

Latest News